Cambridge Investment Research Advisors’s Verona Pharma VRNA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,091	Closed	-$330K	–	3972
2025 Q3	$330K	Sell	3,091 -951	-24%	-$99.3K	﹤0.01%	3036
2025 Q2	$382K	Sell	4,042 -2,126	-34%	-$157K	﹤0.01%	2784
2025 Q1	$392K	Buy	6,168 +1,469	+31%	+$87.9K	﹤0.01%	2655
2024 Q4	$218K	Buy	+4,699	New	+$176K	﹤0.01%	3120

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Cambridge Investment Research Advisors's VRNA Position: Q4 2025 in Review

Cambridge Investment Research Advisors sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 3,091 shares — an estimated $330K sold.

Cambridge Investment Research Advisors first reported a position in VRNA in Q4 2024 and held it in 4 quarters. The position peaked at $392K in Q1 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Cambridge Investment Research Advisors reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Cambridge Investment Research Advisors sold 3,091 Verona Pharma shares in Q4 2025, an estimated $330K.
Cambridge Investment Research Advisors first reported a position in Verona Pharma in Q4 2024 and held it in 4 quarters.
Cambridge Investment Research Advisors's Verona Pharma position peaked at $392K in Q1 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.